Clinical Trial Update: Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing two butenafine hydrochloride 1% creams for interdigital tinea pedis found clinical equivalence; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Pedis

Drugs mentioned

• Butenafine hydrochloride 1% cream (Formulation A) (butenafine hydrochloride)
• Butenafine hydrochloride 1% cream (Formulation B) (butenafine hydrochloride)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Tinea Pedis | Phase 1 | Status: COMPLETED | Results posted: 2009-10-06